外科医生实施的非超声引导腹横肌平面阻滞促进DIEP皮瓣乳房重建术后恢复
一项前瞻性对比队列研究纳入88例乳房切除后即刻DIEP皮瓣重建患者,比较2023年7月前对照组(n=42)与引入外科医生实施TAP阻滞后干预组(n=46)的恢复情况。结果显示TAP组术后第0天疼痛评分更低、PCA需求更少、首次独立活动更早,阿片类药物相关副作用减少。结论认为单次、外科医生实施的非超声引导TAP阻滞提供有效且节省阿片类药物的镇痛并促进恢复。
要点
- 外科医生实施的非超声引导TAP阻滞可显著降低DIEP术后早期疼痛评分
- 该技术减少PCA需求及锁定次数,并提前首次独立活动时间
- TAP阻滞减少恶心、便秘等阿片类药物相关副作用
核心结论
- 单次、外科医生实施的非超声引导TAP阻滞可提供有效且节省阿片类药物的镇痛,并促进DIEP皮瓣重建术后恢复。
- 该技术简单、可重复且成本效益好,使外科医生能直接控制术后镇痛,是ERAS路径的有价值补充。
研究设计与样本
- 前瞻性对比队列研究,纳入88例乳房切除后即刻DIEP皮瓣重建患者。
- 2023年7月前治疗的患者为对照组(n=42),引入外科医生实施TAP阻滞后治疗的患者为干预组(n=46)。
- TAP阻滞在供区使用60 ml 0.25%左布比卡因实施。
主要发现
- TAP组术后第0天疼痛评分显著更低(4.08±1.05 vs 2.78±0.97,p<0.001),第1天和第2天结果相似。
- TAP组术后第0天PCA需求次数更少(10.3±5.52 vs 21±8.6,p<0.002),第1天和第2天效果相似。
- TAP组术后第0天PCA锁定次数显著更少(20.4+9.93 vs 3.9+2.31,p<0.006)。
- TAP组首次独立活动更早(平均2.0天 vs 3.5天,p<0.001)。
- TAP组阿片类药物相关副作用(尤其恶心和便秘)显著减少。
临床怎么用
- 在DIEP皮瓣乳房重建中可考虑由外科医生在供区实施单次非超声引导TAP阻滞(60 ml 0.25%左布比卡因)作为ERAS路径的补充。
- 该技术有助于减少术后早期疼痛和阿片类药物用量,并促进早期活动。
局限性
- 研究为非随机前瞻性对比队列设计,作者指出需要随机对照试验进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Donor-site pain remains a major barrier to early recovery after deep inferior epigastric perforator (DIEP) flap breast reconstruction, despite advances in enhanced recovery after surgery (ERAS) pathways. Ultrasound-guided transversus abdominis plane (TAP) blocks delivered by anaesthetists perioperatively have shown benefit, but the role of a simple, surgeon-delivered, non-ultrasound guided TAP block during DIEP surgery, has not been systematically evaluated. METHODS: A prospective comparative cohort study was conducted by including 88 patients undergoing immediate DIEP flap reconstruction after mastectomy. Patients treated before July 2023 served as controls (n=42), whereas those treated after the introduction of surgeon-administered TAP blocks served as the intervention group (n=46). TAP blocks were delivered at donor sites using 60 ml of 0.25% levobupivacaine. Primary endpoints included pain scores, opioid consumption and patient-controlled analgesia (PCA) lockouts. Secondary outcomes were mobilisation, bowel function and opioid-related side effects. RESULTS: TAP block patients reported significantly lower pain scores on postoperative day 0 (4.08±1.05 vs 2.78±0.97, p<0.001). Similar results were reported on postoperative days 1 and 2. TAP patients required fewer PCA doses on day 0 following surgery (10.3±5.52 vs 21±8.6, p<0.002). Postoperative days 1 and 2 showed similar effects. Significantly fewer PCA lockouts were recorded on day 0 (20.4+9.93 vs 3.9+2.31, p<0.006). Independent mobilisation occurred earlier (mean 2.0 vs 3.5 days, p<0.001), and opiate-related side effects particularly nausea and constipation were significantly reduced. CONCLUSION: A single-dose, surgeon-delivered, non-ultrasound guided TAP blocks provide effective, opioid-sparing analgesia and enhances recovery following DIEP flap reconstruction. This simple, reproducible and cost-effective technique offers surgeons direct control of postoperative analgesia and represents a valuable addition to ERAS pathways. Randomised trials are now warranted.
引用
- Cullen S, Hashem S, Phoenix E, et al. Surgeon-delivered non-ultrasound-guided TAP blocks enhance recovery in DIEP flap breast reconstruction: A prospective comparative cohort study. J Plast Reconstr Aesthet Surg. 2026. PMID: 42498573. doi:10.1016/j.bjps.2026.04.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。